Nouri Alaleh 4
4 · PROCEPT BioRobotics Corp · Filed Mar 19, 2026
Research Summary
AI-generated summary of this filing
PROCEPT (PRCT) EVP Nouri Alaleh Sells Shares
What Happened Nouri Alaleh, EVP, Chief Legal Officer and Corporate Secretary of PROCEPT BioRobotics (PRCT), sold a total of 5,363 shares in open-market transactions on March 19, 2026 for combined proceeds of $139,230. The sales were split into two groups: 3,031 shares at a weighted average price of $25.82 (proceeds $78,258) and 2,332 shares at a weighted average price of $26.15 (proceeds $60,972). These were sales (not purchases).
Key Details
- Transaction date: 2026-03-19 (reported same day)
- Sales: 3,031 shares @ weighted avg $25.82 (range $25.025–$26.020) — $78,258; 2,332 shares @ weighted avg $26.15 (range $26.025–$26.450) — $60,972
- Total sold: 5,363 shares for $139,230
- Shares owned after transaction: not provided in the supplied filing information
- Footnotes: Sales were executed pursuant to a Rule 10b5-1 trading plan adopted June 4, 2025; weighted average prices reported with ranges, and the filer will provide per-price breakdowns on request
- Filing timeliness: Reported on the same date as the transactions (no late filing indicated)
Context These sales were made under a pre-established 10b5-1 trading plan, which allows insiders to sell shares according to a predetermined schedule and is commonly used to avoid trading on nonpublic information. Such planned sales are typically considered routine and do not, by themselves, indicate management’s current view on the company’s prospects.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-03-19$25.82/sh−3,031$78,258→ 107,686 total - Sale
Common Stock
[F1][F3]2026-03-19$26.15/sh−2,332$60,972→ 105,354 total
Footnotes (3)
- [F1]The stock sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.025 to $26.020, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.025 to $26.450, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.